{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:18:23Z","timestamp":1783426703021,"version":"3.54.6"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,7]]},"DOI":"10.7759\/cureus.112201","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:44:00Z","timestamp":1783424640000},"source":"Crossref","is-referenced-by-count":0,"title":["Rituximab Therapy for Fibrillary Glomerulonephritis in an Older Adult With Advanced Chronic Kidney Disease"],"prefix":"10.7759","author":[{"given":"Lena","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayomide O","family":"Gbenle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Spitalewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr SH","year":"2011","unstructured":"Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, Leung N, Fervenza FC. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol. 2011, 6:775-784. 10.2215\/CJN.08300910","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu249","article-title":"Rituximab treatment for fibrillary glomerulonephritis","volume":"29","author":"Hogan J","year":"2014","unstructured":"Hogan J, Restivo M, Canetta PA, Herlitz LC, Radhakrishnan J, Appel GB, Bomback AS. Rituximab treatment for fibrillary glomerulonephritis. Nephrol Dial Transplant. 2014, 29:1925-1931. 10.1093\/ndt\/gfu249","journal-title":"Nephrol Dial Transplant"},{"key":"ref3","article-title":"New developments in the diagnosis of fibrillary glomerulonephritis","volume":"96","author":"Nasr SH","year":"2019","unstructured":"Nasr SH, Fogo AB. New developments in the diagnosis of fibrillary glomerulonephritis. Kidney Int. 2019, 96:581-592.","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr SH","year":"2018","unstructured":"Nasr SH, Vrana JA, Dasari S, et al.. DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis. Kidney Int Rep. 2018, 3:56-64. 10.1016\/j.ekir.2017.07.017","journal-title":"Kidney Int Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa065","article-title":"Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study","volume":"36","author":"Erickson SB","year":"2021","unstructured":"Erickson SB, Zand L, Nasr SH, Alexander MP, Leung N, Drosou ME, Fervenza FC. Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study. Nephrol Dial Transplant. 2021, 36:104-110. 10.1093\/ndt\/gfaa065","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.07.011","article-title":"Rituximab treatment of fibrillary glomerulonephritis","volume":"52","author":"Collins M","year":"2008","unstructured":"Collins M, Navaneethan SD, Chung M, Sloand J, Goldman B, Appel G, Rovin BH. Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis. 2008, 52:1158-1162. 10.1053\/j.ajkd.2008.07.011","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.01.018","article-title":"Recurrence of DNAJB9-positive fibrillary glomerulonephritis after kidney transplantation: a case series","volume":"76","author":"El Ters M","year":"2020","unstructured":"El Ters M, Bobart SA, Cornell LD, et al.. Recurrence of DNAJB9-positive fibrillary glomerulonephritis after kidney transplantation: a case series. Am J Kidney Dis. 2020, 76:500-510. 10.1053\/j.ajkd.2020.01.018","journal-title":"Am J Kidney Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505028-rituximab-therapy-for-fibrillary-glomerulonephritis-in-an-older-adult-with-advanced-chronic-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:44:00Z","timestamp":1783424640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505028-rituximab-therapy-for-fibrillary-glomerulonephritis-in-an-older-adult-with-advanced-chronic-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.112201","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}